Back HCV Prevention

Can Low Volume Syringes Help End HIV and HCV Transmission Among People Who Use Drugs?

Syringes that have a lower "dead space" volume retain less fluid that can harbor HIV and hepatitis C virus (HCV), and switching to this type could help reduce viral transmission among injection drug users, according to an article in the January 2013 issue of International Journal of Drug Policy.

alt

Read more:

Water and Filters Used for Drug Injection May Transmit Hepatitis C Virus

Water, containers, and material used to mix and filter heroin -- not just syringes -- can harbor hepatitis C virus (HCV) and contribute to transmission among injection drug users, according to a study published in the November 5, 2012, advance edition of the Journal of Infectious Diseases.

alt

Read more:

Hepatitis C Sexual Transmission Is Rare among Monogamous Heterosexual Couples

Transmission of hepatitis C virus (HCV) between long-term, monogamous, heterosexual partners can potentially occur, but appears to be very uncommon, according to a study of 500 couples described in the November 23, 2012, advance online edition of Hepatology. Furthermore, the analysis failed to find a link between HCV transmission and any specific sexual activities.

alt

Read more:

HIV+ People Who Get Hepatitis C May Experience Rapid Liver Disease Progression

People with HIV, especially those with advanced immune suppression, who become coinfected with hepatitis C virus (HCV) may experience rapid progression to decompensated cirrhosis and liver-related death, Mt. Sinai researchers reported in the December 21, 2012, advance edition of Clinical Infectious Diseases.

alt

Read more:

HIV11: Sexually Transmitted HCV Rising among HIV+ Gay Men in Europe, but More Are Getting Treated

Hepatitis C virus (HCV) infection rates continue to rise among HIV positive people in Europe, with the highest incidence among injection drug users and men who have sex with men, researchers reported at the 11th International Congress on Drug Therapy in HIV Infection last month in Glasgow. Another study, however, found that HIV/HCV coinfected people are now more likely to receive hepatitis C treatment.

alt

Read more: